Impact of hepatic steatosis on mortality, hepatocellular carcinoma, end-stage liver disease and HBsAg seroclearance in chronic hepatitis B: a United States cohort study
CHB-SLD status was associated with more favorable outcomes, highlighting the complexity of CHB and SLD interactions.
Authors
- Temitope Olasehinde (ORCID: https://orcid.org/0009-0002-3924-7847)
- Robert A. Salata (ORCID: https://orcid.org/0000-0001-8464-0918)
- Mackenzie Cater (ORCID: https://orcid.org/0000-0003-1302-9243)
- Jeffrey M. Jacobson (ORCID: https://orcid.org/0000-0001-7250-1208)
- Abbinaya Elangovan (ORCID: https://orcid.org/0000-0003-4383-1026)
- Frank Mulindwa (ORCID: https://orcid.org/0000-0003-4831-1185)
- George A Yendewa (ORCID: https://orcid.org/0000-0003-4322-8577)
Institutions
- University Hospitals of Cleveland (US)
- United Health Services (US)
- University School (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-02
- DOI
- https://doi.org/10.3389/fimmu.2025.1566925
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Institutes of Health